Extranodal NK-T-cell lymphoma staging: Difference between revisions
(Mahshid) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Extranodal NK-T-cell lymphoma}} | {{Extranodal NK-T-cell lymphoma}} | ||
{{CMG}}; {{AE}} {{AS}} | {{CMG}}; {{AE}} {{RG}}{{AS}} | ||
==Overview== | ==Overview== | ||
There is no established system for the staging of extranodal NK-T-cell lymphoma. A T-staging system, originally designed for sinonasal B-cell lymphoma has been adopted to overcome this problem by taking into account the extent of local tumor involvement.<ref name=Hindawi>Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type. Hindawi Publishing Corporation. http://www.hindawi.com/journals/ah/2010/627401/. Accessed on February 19, 2016 </ref> | There is no established system for the staging of extranodal NK-T-cell lymphoma. A T-staging system, originally designed for sinonasal B-cell lymphoma has been adopted to overcome this problem by taking into account the extent of local tumor involvement.<ref name=Hindawi>Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type. Hindawi Publishing Corporation. http://www.hindawi.com/journals/ah/2010/627401/. Accessed on February 19, 2016 </ref> | ||
Revision as of 14:25, 27 August 2019
|
Extranodal NK-T-cell lymphoma Microchapters |
|
Differentiating Extranodal NK-T-cell lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Extranodal NK-T-cell lymphoma staging On the Web |
|
American Roentgen Ray Society Images of Extranodal NK-T-cell lymphoma staging |
|
Risk calculators and risk factors for Extranodal NK-T-cell lymphoma staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]Sowminya Arikapudi, M.B,B.S. [3]
Overview
There is no established system for the staging of extranodal NK-T-cell lymphoma. A T-staging system, originally designed for sinonasal B-cell lymphoma has been adopted to overcome this problem by taking into account the extent of local tumor involvement.[1]
Staging
There is no established system for the staging of extranodal NK-T-cell lymphoma. A T-staging system, originally designed for sinonasal B-cell lymphoma has been adopted to overcome this problem by taking into account the extent of local tumor involvement.
| Name | Description |
|---|---|
| T1 | Confinement to the nasal cavity |
| T2 | Extension to the maxillary antra, anterior ethmoid sinus or hard palate |
| T3 | Extension to posterior ethmoid sinus, sphenoidal sinus, orbit, superior alveolar bone, cheeks, or superior buccinators space |
| T4 | Involvement of the inferior alveolar bone, inferior buccinators space, infratemporal fossa, nasopharynx, or cranial fossa |
References
- ↑ Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type. Hindawi Publishing Corporation. http://www.hindawi.com/journals/ah/2010/627401/. Accessed on February 19, 2016